Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Surgical Procedures, Operative | 2 | 2017 | 26 | 0.940 |
Why?
|
| Hematuria | 1 | 2023 | 4 | 0.910 |
Why?
|
| Medicaid | 2 | 2023 | 109 | 0.870 |
Why?
|
| Prostatic Neoplasms | 8 | 2024 | 935 | 0.850 |
Why?
|
| Early Detection of Cancer | 5 | 2024 | 336 | 0.790 |
Why?
|
| Health Education | 3 | 2016 | 338 | 0.680 |
Why?
|
| Hospitals, Community | 1 | 2017 | 12 | 0.610 |
Why?
|
| Decision Support Techniques | 2 | 2021 | 47 | 0.600 |
Why?
|
| Physicians | 2 | 2017 | 163 | 0.540 |
Why?
|
| Prostate-Specific Antigen | 5 | 2024 | 118 | 0.470 |
Why?
|
| Retrospective Studies | 8 | 2023 | 2026 | 0.380 |
Why?
|
| Health Facility Size | 1 | 2009 | 5 | 0.340 |
Why?
|
| Certification | 1 | 2009 | 13 | 0.340 |
Why?
|
| Regional Health Planning | 1 | 2009 | 14 | 0.340 |
Why?
|
| Wounds and Injuries | 1 | 2010 | 161 | 0.330 |
Why?
|
| Academic Medical Centers | 2 | 2021 | 60 | 0.320 |
Why?
|
| Social Class | 1 | 2010 | 247 | 0.320 |
Why?
|
| Barbering | 3 | 2016 | 14 | 0.320 |
Why?
|
| Health Status | 1 | 2010 | 380 | 0.290 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2006 | 8 | 0.290 |
Why?
|
| Health Services for the Aged | 1 | 2006 | 20 | 0.280 |
Why?
|
| Drug Prescriptions | 1 | 2006 | 41 | 0.280 |
Why?
|
| Health Policy | 1 | 2006 | 165 | 0.250 |
Why?
|
| Medicare | 1 | 2006 | 195 | 0.250 |
Why?
|
| Humans | 23 | 2024 | 37093 | 0.250 |
Why?
|
| Aged | 10 | 2024 | 6741 | 0.230 |
Why?
|
| Mathematics | 1 | 2003 | 48 | 0.220 |
Why?
|
| Referral and Consultation | 1 | 2023 | 117 | 0.210 |
Why?
|
| Health Promotion | 3 | 2016 | 653 | 0.210 |
Why?
|
| Urology | 1 | 2021 | 7 | 0.200 |
Why?
|
| Mass Screening | 3 | 2024 | 462 | 0.190 |
Why?
|
| United States | 5 | 2024 | 4223 | 0.190 |
Why?
|
| Body Weight | 1 | 2003 | 434 | 0.190 |
Why?
|
| Health Literacy | 1 | 2022 | 105 | 0.180 |
Why?
|
| Primary Health Care | 1 | 2023 | 294 | 0.180 |
Why?
|
| Male | 14 | 2024 | 20025 | 0.160 |
Why?
|
| Decision Making | 2 | 2021 | 203 | 0.160 |
Why?
|
| Middle Aged | 8 | 2024 | 10129 | 0.150 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2017 | 7 | 0.150 |
Why?
|
| Prostate | 2 | 2022 | 154 | 0.150 |
Why?
|
| Delivery of Health Care | 2 | 2017 | 276 | 0.140 |
Why?
|
| Healthcare Disparities | 3 | 2017 | 494 | 0.140 |
Why?
|
| Uncertainty | 1 | 2016 | 26 | 0.140 |
Why?
|
| Los Angeles | 1 | 2017 | 380 | 0.140 |
Why?
|
| Vascular Surgical Procedures | 1 | 2013 | 14 | 0.110 |
Why?
|
| Lower Extremity | 1 | 2013 | 33 | 0.110 |
Why?
|
| Ischemia | 1 | 2013 | 46 | 0.110 |
Why?
|
| Managed Care Programs | 1 | 2013 | 38 | 0.110 |
Why?
|
| Budgets | 1 | 2011 | 9 | 0.100 |
Why?
|
| Fractures, Bone | 1 | 2011 | 53 | 0.100 |
Why?
|
| Child | 3 | 2011 | 3131 | 0.100 |
Why?
|
| Adult | 4 | 2016 | 11712 | 0.090 |
Why?
|
| Hospitalization | 2 | 2011 | 388 | 0.090 |
Why?
|
| Infant | 2 | 2011 | 1046 | 0.090 |
Why?
|
| Thoracic Surgery | 1 | 2009 | 1 | 0.090 |
Why?
|
| Hospitals, Veterans | 1 | 2009 | 15 | 0.090 |
Why?
|
| Medical Records | 1 | 2009 | 41 | 0.090 |
Why?
|
| New York City | 1 | 2010 | 220 | 0.090 |
Why?
|
| General Surgery | 1 | 2009 | 19 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 864 | 0.090 |
Why?
|
| Child, Preschool | 2 | 2011 | 1418 | 0.090 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 56 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 610 | 0.090 |
Why?
|
| Community Networks | 1 | 2010 | 108 | 0.080 |
Why?
|
| Data Collection | 1 | 2009 | 194 | 0.080 |
Why?
|
| California | 3 | 2017 | 476 | 0.080 |
Why?
|
| Residence Characteristics | 1 | 2010 | 322 | 0.080 |
Why?
|
| Social Support | 1 | 2010 | 394 | 0.070 |
Why?
|
| Cost Savings | 1 | 2006 | 13 | 0.070 |
Why?
|
| Social Change | 1 | 2006 | 17 | 0.070 |
Why?
|
| Insurance Coverage | 1 | 2006 | 100 | 0.070 |
Why?
|
| Risk Factors | 2 | 2011 | 3562 | 0.070 |
Why?
|
| Papilloma | 1 | 2004 | 15 | 0.060 |
Why?
|
| Young Adult | 2 | 2011 | 4268 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 664 | 0.060 |
Why?
|
| Calorimetry | 1 | 2003 | 15 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2024 | 191 | 0.060 |
Why?
|
| Glomerular Mesangium | 1 | 2002 | 5 | 0.060 |
Why?
|
| Adolescent | 2 | 2011 | 5363 | 0.050 |
Why?
|
| Oxidants | 1 | 2002 | 45 | 0.050 |
Why?
|
| Comprehension | 1 | 2022 | 33 | 0.050 |
Why?
|
| Weight Loss | 1 | 2003 | 131 | 0.050 |
Why?
|
| Survivors | 1 | 2022 | 136 | 0.050 |
Why?
|
| Reference Values | 2 | 2011 | 212 | 0.050 |
Why?
|
| Glucose | 1 | 2002 | 230 | 0.050 |
Why?
|
| Female | 5 | 2013 | 20969 | 0.050 |
Why?
|
| Curriculum | 1 | 2003 | 265 | 0.050 |
Why?
|
| Patient Participation | 1 | 2021 | 75 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 562 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 974 | 0.040 |
Why?
|
| Incidence | 2 | 2013 | 922 | 0.040 |
Why?
|
| Age Factors | 2 | 2012 | 1033 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 2379 | 0.030 |
Why?
|
| Apoptosis | 1 | 2002 | 1398 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2004 | 1502 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2013 | 88 | 0.030 |
Why?
|
| ROC Curve | 1 | 2013 | 138 | 0.030 |
Why?
|
| Biopsy | 1 | 2013 | 164 | 0.030 |
Why?
|
| Markov Chains | 1 | 2011 | 35 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2011 | 44 | 0.030 |
Why?
|
| New York | 1 | 2011 | 71 | 0.030 |
Why?
|
| Models, Economic | 1 | 2011 | 20 | 0.020 |
Why?
|
| Age Distribution | 1 | 2011 | 225 | 0.020 |
Why?
|
| Probability | 1 | 2011 | 78 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2011 | 144 | 0.020 |
Why?
|
| Logistic Models | 1 | 2013 | 923 | 0.020 |
Why?
|
| Prognosis | 1 | 2013 | 739 | 0.020 |
Why?
|
| Medical Audit | 1 | 2009 | 25 | 0.020 |
Why?
|
| Benchmarking | 1 | 2009 | 29 | 0.020 |
Why?
|
| Policy Making | 1 | 2009 | 31 | 0.020 |
Why?
|
| Program Development | 1 | 2010 | 233 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2011 | 362 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2011 | 894 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2009 | 339 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 1455 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 935 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 60 | 0.020 |
Why?
|
| Radiography | 1 | 2004 | 72 | 0.020 |
Why?
|
| Cytochrome c Group | 1 | 2002 | 16 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 77 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2002 | 77 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2002 | 176 | 0.010 |
Why?
|
| Caspases | 1 | 2002 | 147 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 152 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 239 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2002 | 461 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2002 | 339 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 1039 | 0.010 |
Why?
|
| Cell Survival | 1 | 2002 | 864 | 0.010 |
Why?
|
| Cell Line | 1 | 2002 | 1354 | 0.010 |
Why?
|
| Mice | 1 | 2002 | 5913 | 0.010 |
Why?
|
| Animals | 1 | 2002 | 15081 | 0.000 |
Why?
|